Development of Intravascular Large B-cell Lymphoma during Methotrexate Treatment for Rheumatoid Arthritis

Volume: 61, Issue: 1, Pages: 87 - 90
Published: Jan 1, 2022
Abstract
A 56-year-old woman with rheumatoid arthritis who had been taking methotrexate (MTX) for six years visited our hospital with dyspnea and dizziness. Abdominal ultrasonography revealed mild splenomegaly. Laboratory examinations showed a marked elevation in soluble interleukin-2 receptor and lactate dehydrogenase levels. These abnormalities revealed a spontaneous regression after MTX discontinuation, however, they worsened again four months later....
Paper Details
Title
Development of Intravascular Large B-cell Lymphoma during Methotrexate Treatment for Rheumatoid Arthritis
Published Date
Jan 1, 2022
Volume
61
Issue
1
Pages
87 - 90
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.